KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Novartis Ag (NVS) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $3.2 billion.

  • Novartis Ag's Consolidated Net Income fell 203.96% to $3.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $16.4 billion, marking a year-over-year increase of 1988.27%. This contributed to the annual value of $14.0 billion for FY2025, which is 1698.63% up from last year.
  • Per Novartis Ag's latest filing, its Consolidated Net Income stood at $3.2 billion for Q4 2025, which was down 203.96% from $4.2 billion recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's Consolidated Net Income ranged from a high of $17.0 billion in Q4 2021 and a low of $46.0 million during Q2 2023
  • For the 5-year period, Novartis Ag's Consolidated Net Income averaged around $3.4 billion, with its median value being $3.2 billion (2021).
  • Its Consolidated Net Income has fluctuated over the past 5 years, first tumbled by 9910.92% in 2022, then skyrocketed by 825000.0% in 2024.
  • Quarter analysis of 5 years shows Novartis Ag's Consolidated Net Income stood at $17.0 billion in 2021, then tumbled by 99.11% to $151.0 million in 2022, then surged by 3768.87% to $5.8 billion in 2023, then tumbled by 43.77% to $3.3 billion in 2024, then decreased by 2.04% to $3.2 billion in 2025.
  • Its last three reported values are $3.2 billion in Q4 2025, $4.2 billion for Q3 2025, and $4.5 billion during Q2 2025.